- Market Capitalization, $K 1,030,905
- Shares Outstanding, K 69,750
- Annual Sales, $ 64,890 K
- Annual Income, $ -55,360 K
- 60-Month Beta 1.45
- Price/Sales 16.09
- Price/Cash Flow N/A
- Price/Book 2.89
|Period||Period Low||Period High||Performance|
| || |
+2.51 (+19.04%)since 07/02/21
| || |
-11.80 (-42.92%)since 05/05/21
| || |
-39.66 (-71.65%)since 08/05/20
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth...
ChemoCentryx (CCXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2021 financial results will be released after market close on Monday, August 9, 2021. ChemoCentryx executive management...
Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at email@example.com...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, BLIN, INUV, NEGG, and CCXI.
ChemoCentryx (CCXI) files an amendment to its NDA for avacopan for treatment of ANCA-associated vasculitis. The new PDUFA date is Oct 7. The filing constitutes a major amendment to the original NDA.
/PRNewswire/ -- , LLP is investigating potential claims on behalf of ChemoCentryx Inc. ("ChemoCentryx" or the "Company") ( CCXI) against certain of its current and former officers and directors.
NEW YORK, NY / ACCESSWIRE / July 6, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased...
NEW ORLEANS, LA / ACCESSWIRE / July 6, 2021 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLOV, RIG, CCXI, BHTG, and WBT.
|3rd Resistance Point||17.31|
|2nd Resistance Point||16.74|
|1st Resistance Point||16.22|
|1st Support Level||15.13|
|2nd Support Level||14.56|
|3rd Support Level||14.04|